Regen BioPharma Inc (RGBP)

Currency in USD
0.04010
-0.00760(-15.93%)
Delayed Data·
RGBP Scorecard
Full Analysis
Stock has taken a big hit over the last week
Unusual trading volume
RGBP is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.040100.04750
52 wk Range
0.020000.27000
Key Statistics
Prev. Close
0.0477
Open
0.0414
Day's Range
0.0401-0.0475
52 wk Range
0.02-0.27
Volume
287.34K
Average Volume (3m)
76.81K
1-Year Change
-74.22%
Book Value / Share
-0.26
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
RGBP Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with high price volatility

Regen BioPharma Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Neutral

Regen BioPharma Inc Company Profile

Regen BioPharma, Inc. focuses on the development of regenerative medical applications in the United States. It engages in identifying small molecules that inhibit or express NR2F6 leading to immune cell activation for oncology applications, and immune cell suppression for autoimmune disease. The company is also developing HemaXellarate, a cellular therapeutic product of autologous stromal vascular fraction derived from adipose tissue; dCellVax, an autologous dendritic cell which is treated with an siRNA inhibitor of indoleamine-2,3-dioxygenase; tCellVax which is treated with siRNA to inhibit NR2F6 and the cells re-infused to the patient; DiffronC, uses proprietary siRNA in vivo to inhibit cancer growth and activate T cells; and DuroCAR comprising of CAR-T cells which is treated with an shRNA targeting the gene NR2F6. Regen BioPharma was incorporated in 2012 and is based in La Mesa, California.

Compare RGBP to Peers and Sector

Metrics to compare
RGBP
Peers
Sector
Relationship
P/E Ratio
−1.4x−4.0x−0.5x
PEG Ratio
−0.04−0.080.00
Price/Book
−0.3x2.0x2.6x
Price / LTM Sales
6.6x9.2x3.3x
Upside (Analyst Target)
-85.4%43.4%
Fair Value Upside
Unlock7.2%7.1%Unlock

Earnings

Latest Release
May 16, 2025
EPS / Forecast
-0.13 / --
Revenue / Forecast
59.07K / --
EPS Revisions
Last 90 days

RGBP Income Statement

FAQ

What Stock Exchange Does Regen BioPharma Trade On?

Regen BioPharma is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for Regen BioPharma?

The stock symbol for Regen BioPharma is "RGBP."

What Is the Regen BioPharma Market Cap?

As of today, Regen BioPharma market cap is 1.31M.

What Is Regen BioPharma's Earnings Per Share (TTM)?

The Regen BioPharma EPS (TTM) is -0.07.

From a Technical Analysis Perspective, Is RGBP a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Regen BioPharma Stock Split?

Regen BioPharma has split 2 times.

How Many Employees Does Regen BioPharma Have?

Regen BioPharma has 1 employees.

What is the current trading status of Regen BioPharma (RGBP)?

As of 08 Aug 2025, Regen BioPharma (RGBP) is trading at a price of 0.04, with a previous close of 0.05. The stock has fluctuated within a day range of 0.04 to 0.05, while its 52-week range spans from 0.02 to 0.27.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.